Phibro Animal Health (NASDAQ:PAHC) CEO Sells $1,734,742.87 in Stock

Phibro Animal Health Corporation (NASDAQ:PAHC) CEO Jack Bendheim sold 38,303 shares of the firm’s stock in a transaction on Monday, November 10th. The shares were sold at an average price of $45.29, for a total transaction of $1,734,742.87. Following the completion of the sale, the chief executive officer owned 20,577 shares in the company, valued at $931,932.33. The trade was a 65.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Jack Bendheim also recently made the following trade(s):

• On Friday, November 7th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $42.86, for a total transaction of $150,867.20.
• On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $43.10, for a total value of $151,712.00.
• On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.07, for a total value of $144,566.40.
• On Tuesday, October 28th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.56, for a total value of $146,291.20.
• On Thursday, October 23rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.18, for a total value of $141,433.60.
• On Wednesday, October 22nd, Jack Bendheim sold 11,859 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.27, for a total value of $477,561.93.
• On Monday, October 20th, Jack Bendheim sold 16,075 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.38, for a total transaction of $649,108.50.
• On Friday, October 17th, Jack Bendheim sold 700 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.03, for a total transaction of $28,021.00.
• On Thursday, September 18th, Jack Bendheim sold 7,022 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.26, for a total transaction of $282,705.72.
• On Wednesday, September 10th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.29, for a total transaction of $145,340.80.

Phibro Animal Health Trading Down 0.0%

NASDAQ PAHC opened at $45.32 on Thursday. Phibro Animal Health Corporation has a 12 month low of $16.16 and a 12 month high of $46.42. The company has a market capitalization of $1.84 billion, a price-to-earnings ratio of 38.41, a price-to-earnings-growth ratio of 1.24 and a beta of 0.81. The company has a debt-to-equity ratio of 2.46, a current ratio of 2.76 and a quick ratio of 1.25. The firm’s fifty day moving average price is $40.20 and its 200 day moving average price is $31.53.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.15. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%.The company had revenue of $363.89 million for the quarter, compared to analyst estimates of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, sell-side analysts expect that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, November 26th. This represents a $0.48 annualized dividend and a yield of 1.1%. Phibro Animal Health’s payout ratio is 28.92%.

Hedge Funds Weigh In On Phibro Animal Health

A number of large investors have recently made changes to their positions in PAHC. Barclays PLC boosted its holdings in Phibro Animal Health by 47.4% during the third quarter. Barclays PLC now owns 269,568 shares of the company’s stock worth $10,907,000 after buying an additional 86,719 shares in the last quarter. Quantbot Technologies LP lifted its position in shares of Phibro Animal Health by 54.6% during the 3rd quarter. Quantbot Technologies LP now owns 12,464 shares of the company’s stock valued at $504,000 after acquiring an additional 4,401 shares during the period. Intech Investment Management LLC boosted its stake in shares of Phibro Animal Health by 8.2% during the 3rd quarter. Intech Investment Management LLC now owns 9,147 shares of the company’s stock worth $370,000 after acquiring an additional 697 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in shares of Phibro Animal Health by 55.6% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 4,233 shares of the company’s stock worth $171,000 after acquiring an additional 1,513 shares in the last quarter. Finally, Advisors Preferred LLC acquired a new stake in shares of Phibro Animal Health in the 3rd quarter worth approximately $3,953,000. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Weiss Ratings reissued a “buy (b-)” rating on shares of Phibro Animal Health in a report on Tuesday. Morgan Stanley set a $34.00 price target on shares of Phibro Animal Health in a research note on Thursday, August 28th. Zacks Research cut shares of Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a report on Monday. Bank of America increased their target price on shares of Phibro Animal Health from $19.00 to $27.00 and gave the stock an “underperform” rating in a research note on Friday, August 29th. Finally, JPMorgan Chase & Co. boosted their price target on Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a research report on Friday, November 7th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Phibro Animal Health presently has a consensus rating of “Hold” and an average price target of $31.40.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.